Are you Dr. Mirhadi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 44 invites waiting!
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office8700 Beverly Blvd
West Hollywood, CA 90048Phone(310) 423-4206Fax(310) 659-3332
- Is this information wrong?
- Dr. Amin Mirhadi, MD is a radiation oncologist in West Hollywood, California. He is currently licensed to practice medicine in California. He is affiliated with Cedars-Sinai Medical Center.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2002 - 2006
- Santa Barbara Cottage HospitalInternship, Transitional Year, 2001 - 2002
- University of California, Irvine, School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2002 - 2021
- American Board of Radiology Radiation Oncology
- Breast Cancer Study of Preoperative Pembrolizumab + Radiation Start of enrollment: 2017 Dec 22Stephen Shiao, MD, PHD
Publications & Presentations
- Rate of Whole-Breast Hypofractionated Radiation Therapy Before Versus After Virtual Tumor Board Implementation.Adam C. Powell, Mitchell Ceylan, James W. Long, Uday U. Deshmukh, Bryan A. Loy, Amin J. Mirhadi> ;Organic Process Research & Development. 2021 Jun 1
- 1 citationsThe Association Between Use of Hypofractionation and Treatment Completion Among Recipients of Radiation Therapy Post-Mastectomy.Adam C. Powell, Teresa L. Rogstad, Nandita M. Jacob, James W. Long, Uday U. Deshmukh, Bryan A. Loy, Amin J. Mirhadi> ;Practical radiation oncology. 2019 Nov 6
- 1 citationsPresentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer.Adam C. Powell, Amin J. Mirhadi, Bryan A. Loy, Laura E. Happe, James W. Long, Erin M. Kren, Amit Gupta> ;PLOS ONE. 2017 Jul 14
- Join now to see all
- Health News - Long-Term Hormonal Therapy in Intermediate-Risk Prostate Cancer Patients Does Not Improve Overall SurvivalFebruary 10th, 2016
- Cedars-Sinai Medical CenterLos Angeles, California